Nanoparticle-based local antimicrobial drug delivery

Advanced Drug Delivery Reviews

Volumn 127, Issue , 2018, Pages 46-57

  Gao, Weiwei ^a   Chen, Yijie ^a   Zhang, Yue ^a   Zhang, Qiangzhe ^a   Zhang, Liangfang ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Antimicrobial treatment; Bacterial infection; Local delivery; Nanomedicine; Nanoparticle

Indexed keywords

ANTIBIOTICS; CONTROLLED DRUG DELIVERY; FUNCTIONAL POLYMERS; LIPOSOMES; MEDICAL NANOTECHNOLOGY; MICROORGANISMS; TARGETED DRUG DELIVERY;

ANTI-MICROBIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL TREATMENT; BACTERIAL INFECTIONS; INORGANIC NANOPARTICLE; LOCAL DELIVERY; PATHOGEN INTERACTION; POLYMERIC NANOPARTICLES;

NANOPARTICLES;

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; NANOPARTICLE; POLYMER;

ANTIMICROBIAL THERAPY; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL MEMBRANE; BACTERIAL OUTER MEMBRANE; BACTERIAL VIRULENCE; DRUG DELIVERY SYSTEM; HUMAN; HYDROGEL; MEMBRANE VESICLE; NANOENCAPSULATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; BACTERIUM; CHEMISTRY; DRUG EFFECT; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; DRUG DELIVERY SYSTEMS; HUMANS; NANOPARTICLES;

EID: 85029703659     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2017.09.015     Document Type: Review

References (148)

1. Aminov, R.I., A brief history of the antibiotic era: lessons learned and challenges for the future. Front. Microbiol., 1, 2010, 134.
2. Willing, B.P., Russell, S.L., Finlay, B.B., Shifting the balance: antibiotic effects on host-microbiota mutualism. Nat. Rev. Microbiol. 9 (2011), 233–243.
3. Berdy, J., Thoughts and facts about antibiotics: where we are now and where we are heading. J. Antibiot. (Tokyo) 65 (2012), 385–395.
4. Andersson, D.I., Hughes, D., Antibiotic resistance and its cost: is it possible to reverse resistance?. Nat. Rev. Microbiol. 8 (2010), 260–271.
5. Bush, K., Courvalin, P., Dantas, G., Davies, J., Eisenstein, B., Huovinen, P., Jacoby, G.A., Kishony, R., Kreiswirth, B.N., Kutter, E., Lerner, S.A., Levy, S., Lewis, K., Lomovskaya, O., Miller, J.H., Mobashery, S., Piddock, L.J.V., Projan, S., Thomas, C.M., Tomasz, A., Tulkens, P.M., Walsh, T.R., Watson, J.D., Witkowski, J., Witte, W., Wright, G., Yeh, P., Zgurskaya, H.I., Tackling antibiotic resistance. Nat. Rev. Microbiol. 9 (2011), 894–896.
6. Li, L.C., Deng, J., Stephens, D., Polyanhydride implant for antibiotic delivery - from the bench to the clinic. Adv. Drug Deliv. Rev. 54 (2002), 963–986.
7. Wu, P., Grainger, D.W., Drug/device combinations for local drug therapies and infection prophylaxis. Biomaterials 27 (2006), 2450–2467.
8. Zhang, Y., Chan, H.F., Leong, K.W., Advanced materials and processing for drug delivery: the past and the future. Adv. Drug Deliv. Rev. 65 (2013), 104–120.
9. Kluin, O.S., van der Mei, H.C., Busscher, H.J., Neut, D., Biodegradable vs non-biodegradable antibiotic delivery devices in the treatment of osteomyelitis. Expert Opin. Drug Deliv. 10 (2013), 341–351.
10. ter Boo, G.-J.A., Grijpma, D.W., Moriarty, T.E., Richards, R.G., Eglin, D., Antimicrobial delivery systems for local infection prophylaxis in orthopedic- and trauma surgery. Biomaterials 52 (2015), 113–125.
11. Inzana, J.A., Schwarz, E.M., Kates, S.L., Awad, H.A., Biomaterials approaches to treating implant-associated osteomyelitis. Biomaterials 81 (2016), 58–71.
12. Farokhzad, O.C., Langer, R., Impact of nanotechnology on drug delivery. ACS Nano 3 (2009), 16–20.
13. Shi, J., Votruba, A.R., Farokhzad, O.C., Langer, R., Nanotechnology in drug delivery and tissue engineering: from discovery to applications. Nano Lett. 10 (2010), 3223–3230.
14. Zhang, L., Pornpattananangkul, D., Hu, C.M.J., Huang, C.M., Development of nanoparticles for antimicrobial drug delivery. Curr. Med. Chem. 17 (2010), 585–594.
15. Gao, W., Thamphiwatana, S., Angsantikul, P., Zhang, L., Nanoparticle approaches against bacterial infections. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 6 (2014), 532–547.
16. Gonda, I., The ascent of pulmonary drug delivery. J. Pharm. Sci. 89 (2000), 940–945.
17. Ponchel, G., Irache, J.M., Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Adv. Drug Deliv. Rev. 34 (1998), 191–219.
18. Haack, T., Abdelilah-Seyfried, S., The force within: endocardial development, mechanotransduction and signalling during cardiac morphogenesis. Development 143 (2016), 373–386.
19. Nielubowicz, G.R., Mobley, H.L.T., Host-pathogen interactions in urinary tract infection. Nat. Rev. Urol. 7 (2010), 430–441.
20. Canning, C.R., Greaney, M.J., Dewynne, J.N., Fitt, A.D., Fluid flow in the anterior chamber of a human eye. IMA J. Math. Appl. Med. Biol. 19 (2002), 31–60.
21. Barza, M., Cuchural, G., General-principles of antibiotic tissue penetration. J. Antimicrob. Chemother. 15 (1985), 59–75.
22. Lagler, H., Zeitlinger, M., Tissue penetration of antibiotics does the treatment reach the target site?. Med. Klin. Intensivmed. Notfmed. 109 (2014), 175–181.
23. Abdullah, Z., Knolle, P.A., Scaling of immune responses against intracellular bacterial infection. EMBO J. 33 (2014), 2283–2294.
24. Asner, S.A., Morre, S.A., Bochud, P.Y., Greub, G., Host factors and genetic susceptibility to infections due to intracellular bacteria and fastidious organisms. Clin. Microbiol. Infect. 20 (2014), 1246–1253.
25. Baietto, L., Corcione, S., Pacini, G., Di Perri, G., D'Avolio, A., De Rosa, F.G., A 30-years review on pharmacokinetics of antibiotics: is the right time for pharmacogenetics?. Curr. Drug Metab. 15 (2014), 581–598.
26. Edwards, D.A., Hanes, J., Caponetti, G., Hrkach, J., BenJebria, A., Eskew, M.L., Mintzes, J., Deaver, D., Lotan, N., Langer, R., Large porous particles for pulmonary drug delivery. Science 276 (1997), 1868–1871.
27. Crowder, T.M., Rosati, J.A., Schroeter, J.D., Hickey, A.J., Martonen, T.B., Fundamental effects of particle morphology on lung delivery: predictions of Stokes' law and the particular relevance to dry powder inhaler formulation and development. Pharm. Res. 19 (2002), 239–245.
28. Ohashi, K., Kabasawa, T., Ozeki, T., Okada, H., One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis. J. Control. Release 135 (2009), 19–24.
29. Li, Y.-Z., Sun, X., Gong, T., Liu, J., Zuo, J., Zhang, Z.-R., Inhalable microparticles as carriers for pulmonary delivery of thymopentin-loaded solid lipid nanoparticles. Pharm. Res. 27 (2010), 1977–1986.
30. Li, J., Esteban-Fernandez de Avila, B., Gao, W., Zhang, L., Wang, J., Micro/nanorobots for biomedicine: delivery, surgery, sensing and detoxification. Science Robot., 2, 2017, eaam6431.
31. Li, J., Angsantikul, P., Liu, W., de Avila, B.E.-F., Thamphiwatana, S., Xu, M., Sandraz, E., Wang, X., Delezuk, J., Gao, W., Zhang, L., Wang, J., Micromotors spontaneously neutralize gastric acid for pH-responsive payload release. Angew. Chem. Int. Ed. 56 (2017), 2156–2161.
32. Li, J.X., Thamphiwatana, S., Liu, W.J., de Avila, B.E.F., Angsantikul, P., Sandraz, E., Wang, J.X., Xu, T.L., Soto, F., Ramez, V., Wang, X.L., Gao, W., Zhang, L., Wang, J., Enteric micromotor can selectively position and spontaneously propel in the gastrointestinal tract. ACS Nano 10 (2016), 9536–9542.
33. Zhang, Y., Zhang, J., Chen, M.G., Gong, H., Tharnphiwatana, S., Eckmann, L., Gao, W., Zhang, L., A bioadhesive nanoparticle-hydrogel hybrid system for localized antimicrobial drug delivery. ACS Appl. Mater. Interfaces 8 (2016), 18367–18374.
34. Lee, H., Dellatore, S.M., Miller, W.M., Messersmith, P.B., Mussel-inspired surface chemistry for multifunctional coatings. Science 318 (2007), 426–430.
35. Lee, H., Scherer, N.F., Messersmith, P.B., Single-molecule mechanics of mussel adhesion. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 12999–13003.
36. Kastrup, C.J., Nahrendorf, M., Figueiredo, J.L., Lee, H., Kambhampati, S., Lee, T., Cho, S.W., Gorbatov, R., Iwamoto, Y., Dang, T.T., Dutta, P., Yeon, J.H., Cheng, H., Pritchard, C.D., Vegas, A.J., Siegel, C.D., MacDougall, S., Okonkwo, M., Thai, A., Stone, J.R., Coury, A.J., Weissleder, R., Langer, R., Anderson, D.G., Painting blood vessels and atherosclerotic plaques with an adhesive drug depot. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), 21444–21449.
37. Silver, B., Behrouz, R., Silliman, S., Bacterial endocarditis and cerebrovascular disease. Curr. Neurol. Neurosci. Rep., 16, 2016.
38. Cahill, T.J., Baddour, L.M., Habib, G., Hoen, B., Salaun, E., Pettersson, G.B., Schafers, H.J., Prendergast, B.D., Challenges in infective endocarditis. J. Am. Coll. Cardiol. 69 (2017), 325–344.
39. Cusumano, C.K., Pinkner, J.S., Han, Z.F., Greene, S.E., Ford, B.A., Crowley, J.R., Henderson, J.P., Janetka, J.W., Hultgren, S.J., Treatment and prevention of urinary tract infection with orally active FimH inhibitors. Sci. Transl. Med., 3, 2011, 109ra115.
40. Nix, D.E., Goodwin, S.D., Peloquin, C.A., Rotella, D.L., Schentag, J.J., Antibiotic tissue penetration and its relevance - impact of tissue penetration on infection response. Antimicrob. Agents Chemother. 35 (1991), 1953–1959.
41. Wagner, C., Sauermanna, R., Joukhadar, C., Principles of antibiotic penetration into abscess fluid. Pharmacology 78 (2006), 1–10.
42. Dillen, K., Bridts, C., Van der Veken, P., Cos, P., Vandervoort, J., Augustyns, K., Stevens, W., Ludwig, A., Adhesion of PLGA or Eudragit (r)/PLGA nanoparticles to staphylococcus and, pseudomonas. Int. J. Pharm. 349 (2008), 234–240.
43. Sambhy, V., Peterson, B.R., Sen, A., Antibacterial and hemolytic activities of pyridinium polymers as a function of the spatial relationship between the positive charge and the pendant alkyl tail. Angew. Chem. Int. Ed. 47 (2008), 1250–1254.
44. Radovic-Moreno, A.F., Lu, T.K., Puscasu, V.A., Yoon, C.J., Langer, R., Farokhzad, O.C., Surface charge-switching polymeric nanoparticles for bacterial cell wall-targeted delivery of antibiotics. ACS Nano 6 (2012), 4279–4287.
45. Kenawy, E.R., Worley, S.D., Broughton, R., The chemistry and applications of antimicrobial polymers: a state-of-the-art review. Biomacromolecules 8 (2007), 1359–1384.
46. Liu, L.H., Xu, K.J., Wang, H.Y., Tan, P.K.J., Fan, W.M., Venkatraman, S.S., Li, L.J., Yang, Y.Y., Self-assembled cationic peptide nanoparticles as an efficient antimicrobial agent. Nat. Nanotechnol. 4 (2009), 457–463.
47. Nederberg, F., Zhang, Y., Tan, J.P.K., Xu, K.J., Wang, H.Y., Yang, C., Gao, S.J., Guo, X.D., Fukushima, K., Li, L.J., Hedrick, J.L., Yang, Y.Y., Biodegradable nanostructures with selective lysis of microbial membranes. Nat. Chem. 3 (2011), 409–414.
48. Oren, Z., Shai, Y., Cyclization of a cytolytic amphipathic alpha-helical peptide and its diastereomer: effect on structure, interaction with model membranes, and biological function. Biochemistry 39 (2000), 6103–6114.
49. Fernandez-Lopez, S., Kim, H.S., Choi, E.C., Delgado, M., Granja, J.R., Khasanov, A., Kraehenbuehl, K., Long, G., Weinberger, D.A., Wilcoxen, K.M., Ghadiri, M.R., Antibacterial agents based on the cyclic D,L-alpha-peptide architecture. Nature 412 (2001), 452–455.
50. Ewald, C., Kuhn, S., Kalff, R., Pyogenic infections of the central nervous system secondary to dental affections - a report of six cases. Neurosurg. Rev. 29 (2006), 163–166.
51. Bert, F., Ouahes, O., Lambertzechovsky, N., Brain-abscess due to Bacillus macerans following a penetrating periorbital injury. J. Clin. Microbiol. 33 (1995), 1950–1953.
52. Choi, S.K., Myc, A., Silpe, J.E., Sumit, M., Wong, P.T., McCarthy, K., Desai, A.M., Thomas, T.P., Kotlyar, A., Holl, M.M.B., Orr, B.G., Baker, J.R., Dendrimer-based multivalent vancomycin nanoplatform for targeting the drug-resistant bacterial surface. ACS Nano 7 (2013), 214–228.
53. Choi, K.H., Lee, H.J., Park, B.J., Wang, K.K., Shin, E.P., Park, J.C., Kim, Y.K., Oh, M.K., Kim, Y.R., Photosensitizer and vancomycin-conjugated novel multifunctional magnetic particles as photoinactivation agents for selective killing of pathogenic bacteria. Chem. Commun. 48 (2012), 4591–4593.
54. Qi, G.B., Li, L.L., Yu, F.Q., Wang, H., Vancomycin-modified mesoporous silica nanoparticles for selective recognition and killing of pathogenic gram-positive bacteria over macrophage-like cells. ACS Appl. Mater. Interfaces 5 (2013), 10874–10881.
55. Chen, J., Zhang, C., Liu, Q.F., Shao, X.Y., Feng, C.C., Shen, Y.H., Zhang, Q.Z., Jiang, X.G., Solanum tuberosum lectin-conjugated PLGA nanoparticles for nose-to-brain delivery: in vivo and in vitro evaluations. J. Drug Target. 20 (2012), 174–184.
56. Huang, P.J., Tay, L.L., Tanha, J., Ryan, S., Chau, L.K., Single-domain antibody-conjugated nanoaggregate-embedded beads for targeted detection of pathogenic bacteria. Chem. Eur. J. 15 (2009), 9330–9334.
57. Tay, L.L., Huang, P.J., Tanha, J., Ryan, S., Wu, X.H., Hulse, J., Chau, L.K., Silica encapsulated sers nanoprobe conjugated to the bacteriophage tailspike protein for targeted detection of Salmonella. Chem. Commun. 48 (2012), 1024–1026.
58. Chen, F., Zhou, J., Luo, F.L., Mohammed, A.B., Zhang, X.L., Aptamer from whole-bacterium SELEX as new therapeutic reagent against virulent mycobacterium tuberculosis. Biochem. Biophys. Res. Commun. 357 (2007), 743–748.
59. Duan, N., Wu, S.J., Chen, X.J., Huang, Y.K., Xia, Y., Ma, X.Y., Wang, Z.P., Selection and characterization of aptamers against salmonella typhimurium using whole-bacterium systemic evolution of ligands by exponential enrichment (SELEX). J. Agric. Food Chem. 61 (2013), 3229–3234.
60. Song, M.Y., Jurng, J., Park, Y.K., Kim, B.C., An aptamer cocktail-functionalized photocatalyst with enhanced antibacterial efficiency towards target bacteria. J. Hazard. Mater. 318 (2016), 247–254.
61. Hu, C.M.J., Zhang, L., Aryal, S., Cheung, C., Fang, R.H., Zhang, L., Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 10980–10985.
62. Gao, W., Zhang, L., Coating nanoparticles with cell membranes for targeted drug delivery. J. Drug Target. 23 (2015), 619–626.
63. Hu, C.-M.J., Fang, R.H., Wang, K.-C., Luk, B.T., Thamphiwatana, S., Dehaini, D., Phu, N., Angsantikul, P., Wen, C.H., Kroll, A.V., Carpenter, C., Ramesh, M., Qu, V., Patel, S.H., Zhu, J., Shi, W., Hofman, F.M., Chen, T.C., Gao, W., Zhang, K., Chien, S., Zhang, L., Nanoparticle biointerfacing by platelet membrane cloaking. Nature 526 (2015), 118–121.
64. Fitzgerald, J.R., Foster, T.J., Cox, D., The interaction of bacterial pathogens with platelets. Nat. Rev. Microbiol. 4 (2006), 445–457.
65. Johnston, D.G.W., Kearney, J., Zaslona, Z., Williams, M.A., O'Neill, L.A.J., Corr, S.C., MicroRNA-21 limits uptake of Listeria monocytogenes by macrophages to reduce the intracellular niche and control infection. Front. Cell. Infect. Microbiol., 7, 2017, 201.
66. Witter, A.R., Okunnu, B.M., Berg, R.E., The essential role of neutrophils during infection with the intracellular bacterial pathogen listeria monocytogenes. J. Immunol. 197 (2016), 1557–1565.
67. Rikihisa, Y., Mechanisms of obligatory intracellular infection with Anaplasma phagocytophilum. Clin. Microbiol. Rev. 24 (2011), 469–489.
68. Kentner, D., Martano, G., Callon, M., Chiquet, P., Brodmann, M., Burton, O., Wahlander, A., Nanni, P., Delmotte, N., Grossmann, J., Limenitakis, J., Schlapbach, R., Kiefer, P., Vorholt, J.A., Hiller, S., Bumann, D., Shigella reroutes host cell central metabolism to obtain high-flux nutrient supply for vigorous intracellular growth. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), 9929–9934.
69. Mellouk, N., Enninga, J., Cytosolic access of intracellular bacterial pathogens: the Shigella paradigm. Front. Cell. Infect. Microbiol., 6, 2016.
70. Hartland, E.L., Bacterial pathogenesis: Legionella phosphoinositide tailoring. Nat. Microbiol., 2, 2017, 17013.
71. Speiser, Y., Zusman, T., Pasechnek, A., Segal, G., The Legionella pneumophila incomplete phosphotransferase system is required for optimal intracellular growth and maximal expression of PmrA-regulated effectors. Infect. Immun., 85, 2017, e00121-17.
72. Kaur, S., Harjai, K., Chhibber, S., Bacteriophage-aided intracellular killing of engulfed methicillin-resistant Staphylococcus aureus (MRSA) by murine macrophages. Appl. Microbiol. Biotechnol. 98 (2014), 4653–4661.
73. Pumerantz, A., Muppidi, K., Agnihotri, S., Guerra, C., Venketaraman, V., Wang, J., Betageri, G., Preparation of liposomal vancomycin and intracellular killing of meticillin-resistant Staphylococcus aureus (MRSA). Int. J. Antimicrob. Agents 37 (2011), 140–144.
74. Baxt, L.A., Garza-Mayers, A.C., Goldberg, M.B., Bacterial subversion of host innate immune pathways. Science 340 (2013), 697–701.
75. Eisenreich, W., Heesemann, J., Rudel, T., Goebel, W., Metabolic host responses to infection by intracellular bacterial pathogens. Front. Cell. Infect. Microbiol., 3, 2013, 24.
76. Hodgson, K., Morris, J., Bridson, T., Govan, B., Rush, C., Ketheesan, N., Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections. Immunology 144 (2015), 171–185.
77. Abed, N., Couvreur, P., Nanocarriers for antibiotics: a promising solution to treat intracellular bacterial infections. Int. J. Antimicrob. Agents 43 (2014), 485–496.
78. Kaim, A.H., Wischer, T., O'Reilly, T., Jundt, G., Frohlich, J., von Schulthess, G.K., Allegrini, P.R., MR imaging with ultrasmall superparamagnetic iron oxide particles in experimental soft-tissue infections in rats. Radiology 225 (2002), 808–814.
79. Kisich, K.O., Gelperina, S., Higgins, M.P., Wilson, S., Shipulo, E., Oganesyan, E., Heifets, L., Encapsulation of moxifloxacin within poly(butyl cyanoacrylate) nanoparticles enhances efficacy against intracellular mycobacterium tuberculosis. Int. J. Pharm. 345 (2007), 154–162.
80. Semiramoth, N., Di Meo, C., Zouhiri, F., Said-Hassane, F., Valetti, S., Gorges, R., Nicolas, V., Poupaert, J.H., Chollet-Martin, S., Desmaele, D., Gref, R., Couvreur, P., Self-assembled squalenoylated penicillin bioconjugates: an original approach for the treatment of intracellular infections. ACS Nano 6 (2012), 3820–3831.
81. Toti, U.S., Guru, B.R., Hali, M., McPharlin, C.M., Wykes, S.M., Panyam, J., Whittum-Hudson, J.A., Targeted delivery of antibiotics to intracellular chlamydial infections using PLGA nanoparticles. Biomaterials 32 (2011), 6606–6613.
82. Clemens, D.L., Lee, B.Y., Xue, M., Thomas, C.R., Meng, H., Ferris, D., Nel, A.E., Zink, J.I., Horwitz, M.A., Targeted intracellular delivery of antituberculosis drugs to mycobacterium tuberculosis-infected macrophages via functionalized mesoporous silica nanoparticles. Antimicrob. Agents Chemother. 56 (2012), 2535–2545.
83. Maya, S., Indulekha, S., Sukhithasri, V., Smitha, K.T., Nair, S.V., Jayakumar, R., Biswas, R., Efficacy of tetracycline encapsulated o-carboxymethyl chitosan nanoparticles against intracellular infections of Staphylococcus aureus. Int. J. Biol. Macromol. 51 (2012), 392–399.
84. Kamaruzzaman, N.F., Firdessa, R., Good, L., Bactericidal effects of polyhexamethylene biguanide against intracellular Staphylococcus aureus EMRSA-15 and USA 300. J. Antimicrob. Chemother. 71 (2016), 1252–1259.
85. Chellat, F., Merhi, Y., Moreau, A., Yahia, L., Therapeutic potential of nanoparticulate systems for macrophage targeting. Biomaterials 26 (2005), 7260–7275.
86. Edagwa, B.J., Guo, D.W., Puligujja, P., Chen, H., McMillan, J., Liu, X.M., Gendelman, H.E., Narayanasamy, P., Long-acting antituberculous therapeutic nanoparticles target macrophage endosomes. FASEB J. 28 (2014), 5071–5082.
87. Vyas, S.P., Kannan, M.E., Jain, S., Mishra, V., Singh, P., Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages. Int. J. Pharm. 269 (2004), 37–49.
88. Lee, W.H., Loo, C.Y., Traini, D., Young, P.M., Nano- and micro-based inhaled drug delivery systems for targeting alveolar macrophages. Expert Opin. Drug Deliv. 12 (2015), 1009–1026.
89. Blair, J.M.A., Webber, M.A., Baylay, A.J., Ogbolu, D.O., Piddock, L.J.V., Molecular mechanisms of antibiotic resistance. Nat. Rev. Microbiol. 13 (2015), 42–51.
90. Brooks, B.D., Brooks, A.E., Therapeutic strategies to combat antibiotic resistance. Adv. Drug Deliv. Rev. 78 (2014), 14–27.
91. Karam, G., Chastre, J., Wilcox, M.H., Vincent, J.-L., Antibiotic strategies in the era of multidrug resistance. Crit. Care, 20, 2016, 136.
92. Woolhouse, M., Waugh, C., Perry, M.R., Nair, H., Global disease burden due to antibiotic resistance - state of the evidence. J. Glob. Health, 6, 2016, 010306.
93. Dodds, D.R., Antibiotic resistance: a current epilogue. Biochem. Pharmacol. 134 (2017), 139–146.
94. Drulis-Kawa, Z., Dorotkiewicz-Jach, A., Liposomes as delivery systems for antibiotics. Int. J. Pharm. 387 (2010), 187–198.
95. Gao, W., Hu, C.-M.J., Fang, R.H., Zhang, L., Liposome-like nanostructures for drug delivery. J. Mater. Chem. B 1 (2013), 6569–6585.
96. Mugabe, C., Halwani, M., Azghani, A.O., Lafrenie, R.M., Omri, A., Mechanism of enhanced activity of liposome-entrapped aminoglycosides against resistant strains of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 50 (2006), 2016–2022.
97. Ma, Y.F., Wang, Z., Zhao, W., Lu, T.L., Wang, R.T., Mei, Q.B., Chen, T., Enhanced bactericidal potency of nanoliposomes by modification of the fusion activity between liposomes and bacterium. Int. J. Nanomedicine 8 (2013), 2351–2360.
98. Wilschut, J., Hoekstra, D., Membrane-fusion - from liposomes to biological-membranes. Trends Biochem. Sci. 9 (1984), 479–483.
99. Yang, D., Pornpattananangkul, D., Nakatsuji, T., Chan, M., Carson, D., Huang, C.M., Zhang, L., The antimicrobial activity of liposomal lauric acids against propionibacterium acnes. Biomaterials 30 (2009), 6035–6040.
100. Huang, C.M., Chen, C.H., Pornpattananangkul, D., Zhang, L., Chan, M., Hsieh, M.F., Zhang, L., Eradication of drug resistant Staphylococcus aureus by liposomal oleic acids. Biomaterials 32 (2011), 214–221.
101. Chen, C.H., Wang, Y.H., Nakatsuji, T., Liu, Y.T., Zouboulis, C.C., Gallo, R.L., Zhang, L., Hsieh, M.F., Huang, C.M., An innate bactericidal oleic acid effective against skin infection of methicillin-resistant Staphylococcus aureus: a therapy concordant with evolutionary medicine. J. Microbiol. Biotechnol. 21 (2011), 391–399.
102. Obonyo, M., Zhang, L., Thamphiwatana, S., Pornpattananangkul, D., Fu, V., Zhang, L., Antibacterial activities of liposomal linolenic acids against antibiotic-resistant Helicobacter pylori. Mol. Pharm. 9 (2012), 2677–2685.
103. Pornpattananangkul, D., Fu, V., Thamphiwatana, S., Zhang, L., Chen, M., Vecchio, J., Gao, W., Huang, C.-M., Zhang, L., In vivo treatment of Propionibacterium acnes infection with liposomal lauric acids. Adv. Healthc. Mater. 2 (2013), 1322–1328.
104. Thamphiwatana, S., Gao, W., Obonyo, M., Zhang, L., In vivo treatment of Helicobacter pylori infection with liposomal linolenic acid reduces colonization and ameliorates inflammation. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), 17600–17605.
105. Jung, S.W., Thamphiwatana, S., Zhang, L., Obonyo, M., Mechanism of antibacterial activity of liposomal linolenic acid against Helicobacter pylori. PLoS One, 10, 2015, e0116519.
106. Bayramov, D.F., Neff, J.A., Beyond conventional antibiotics - new directions for combination products to combat biofilm. Adv. Drug Deliv. Rev. 112 (2016), 48–60.
107. Kohanski, M.A., Dwyer, D.J., Collins, J.J., How antibiotics kill bacteria: from targets to networks. Nat. Rev. Microbiol. 8 (2010), 423–435.
108. Li, P., Li, J., Wu, C.Z., Wu, Q.S., Li, J., Synergistic antibacterial effects of beta-lactam antibiotic combined with silver nanoparticles. Nanotechnology 16 (2005), 1912–1917.
109. Fayaz, A.M., Balaji, K., Girilal, M., Yadav, R., Kalaichelvan, P.T., Venketesan, R., Biogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: a study against Gram-positive and Gram-negative bacteria. Nanomed. Nanotechnol. Biol. Med. 6 (2010), 103–109.
110. Banoee, M., Seif, S., Nazari, Z.E., Jafari-Fesharaki, P., Shahverdi, H.R., Moballegh, A., Moghaddam, K.M., Shahverdi, A.R., Zno nanoparticles enhanced antibacterial activity of ciprofloxacin against Staphylococcus aureus and Escherichia coli. J. Biomed. Mater. Res. B Appl. Biomater. 93 (2010), 557–561.
111. Gu, H.W., Ho, P.L., Tong, E., Wang, L., Xu, B., Presenting vancomycin on nanoparticles to enhance antimicrobial activities. Nano Lett. 3 (2003), 1261–1263.
112. Xiong, M.H., Li, Y.J., Bao, Y., Yang, X.Z., Hu, B., Wang, J., Bacteria-responsive multifunctional nanogel for targeted antibiotic delivery. Adv. Mater. 24 (2012), 6175–6180.
113. Li, Y.M., Liu, G.H., Wang, X.R., Hu, J.M., Liu, S.Y., Enzyme-responsive polymeric vesicles for bacterial-strain-selective delivery of antimicrobial agents. Angew. Chem. Int. Ed. 55 (2016), 1760–1764.
114. Pornpattananangkul, D., Olson, S., Aryal, S., Sartor, M., Huang, C.M., Vecchio, K., Zhang, L., Stimuli-responsive liposome fusion mediated by gold nanoparticles. ACS Nano 4 (2010), 1935–1942.
115. Thamphiwatana, S., Fu, V., Zhu, J., Lu, D., Gao, W., Zhang, L., Nanoparticle-stabilized liposomes for pH-responsive gastric drug delivery. Langmuir 29 (2013), 12228–12233.
116. Pornpattananangkul, D., Zhang, L., Olson, S., Aryal, S., Obonyo, M., Vecchio, K., Huang, C.M., Zhang, L., Bacterial toxin-triggered drug release from gold nanoparticle-stabilized liposomes for the treatment of bacterial infection. J. Am. Chem. Soc. 133 (2011), 4132–4139.
117. Thamphiwatana, S., Gao, W.W., Pornpattananangkul, D., Zhang, Q.Z., Fu, V., Li, J.Y., Li, J.M., Obonyo, M., Zhang, L., Phospholipase A2-responsive antibiotic delivery via nanoparticle-stabilized liposomes for the treatment of bacterial infection. J. Mater. Chem. B 2 (2014), 8201–8207.
118. Hung, D.T., Shakhnovich, E.A., Pierson, E., Mekalanos, J.J., Small-molecule inhibitor of Vibrio cholerae virulence and intestinal colonization. Science 310 (2005), 670–674.
119. Rasko, D.A., Moreira, C.G., Li, D.R., Reading, N.C., Ritchie, J.M., Waldor, M.K., Williams, N., Taussig, R., Wei, S.G., Roth, M., Hughes, D.T., Huntley, J.F., Fina, M.W., Falck, J.R., Sperandio, V., Targeting qSEC signaling and virulence for antibiotic development. Science 321 (2008), 1078–1080.
120. Cegelski, L., Marshall, G.R., Eldridge, G.R., Hultgren, S.J., The biology and future prospects of antivirulence therapies. Nat. Rev. Microbiol. 6 (2008), 17–27.
121. Rasko, D.A., Sperandio, V., Anti-virulence strategies to combat bacteria-mediated disease. Nat. Rev. Drug Discov. 9 (2010), 117–128.
122. Barczak, A.K., Hung, D.T., Productive steps toward an antimicrobial targeting virulence. Curr. Opin. Microbiol. 12 (2009), 490–496.
123. Allen, R.C., Popat, R., Diggle, S.P., Brown, S.P., Targeting virulence: can we make evolution-proof drugs?. Nat. Rev. Microbiol. 12 (2014), 300–308.
124. Paul, M., Leibovici, L., Combination antimicrobial treatment versus monotherapy: the contribution of meta-analyses. Infect. Dis. Clin. N. Am. 23 (2009), 277–293.
125. Beckham, K.S.H., Roe, A.J., From screen to target: insights and approaches for the development of anti-virulence compounds. Front. Cell Infect. Microbiol., 4, 2014, 139.
126. Maura, D., Ballok, A.E., Rahme, L.G., Considerations and caveats in anti-virulence drug development. Curr. Opin. Microbiol. 33 (2016), 41–46.
127. Schiavo, G., van der Goot, F.G., The bacterial toxin toolkit. Nat. Rev. Mol. Cell Biol. 2 (2001), 530–537.
128. Page, R., Peti, W., Toxin-antitoxin systems in bacterial growth arrest and persistence. Nat. Chem. Biol. 12 (2016), 208–214.
129. Hu, C.M.J., Fang, R.H., Copp, J., Luk, B.T., Zhang, L., A biomimetic nanosponge that absorbs pore-forming toxins. Nat. Nanotechnol. 8 (2013), 336–340.
130. Wang, F., Gao, W.W., Thamphiwatana, S., Luk, B.T., Angsantikul, P., Zhang, Q.Z., Hu, C.M.J., Fang, R.H., Copp, J.A., Pornpattananangkul, D., Lu, W., Zhang, L., Hydrogel retaining toxin-absorbing nanosponges for local treatment of methicillin-resistant Staphylococcus aureus infection. Adv. Mater. 27 (2015), 3437–3443.
131. Gao, W., Vecchio, D., Li, J.M., Zhu, J.Y., Zhang, Q.Z., Fu, V., Li, J.Y., Thamphiwatana, S., Lu, D., Zhang, L., Hydrogel containing nanoparticle-stabilized liposomes for topical antimicrobial delivery. ACS Nano 8 (2014), 2900–2907.
132. Gao, W., Zhang, Y., Zhang, Q., Zhang, L., Nanoparticle-hydrogel: a hybrid biomaterial system for localized drug delivery. Ann. Biomed. Eng. 44 (2016), 2049–2061.
133. Li, L.L., Xu, J.H., Qi, G.B., Zhao, X.Z., Yu, F.Q., Wang, H., Core-shell supramolecular gelatin nanoparticles for adaptive and “on-demand” antibiotic delivery. ACS Nano 8 (2014), 4975–4983.
134. Zhang, J., Gao, W., Fang, R.H., Dong, A., Zhang, L., Synthesis of nanogels via cell membrane-templated polymerization. Small 11 (2015), 4309–4313.
135. Zhang, Y., Zhang, J., Chen, W., Angsantikul, P., Spiekermann, K., Fang, R.H., Gao, W., Zhang, L., Erythrocyte membrane-coated nanogel for combinatorial antivirulence and responsive antimicrobial delivery against Staphylococcus aureus infection. J. Control. Release 263 (2017), 185–191.
136. Hu, C.M.J., Fang, R.H., Luk, B.T., Zhang, L., Nanoparticle-detained toxins for safe and effective vaccination. Nat. Nanotechnol. 8 (2013), 933–938.
137. Hu, C.M.J., Zhang, L., Nanotoxoid vaccines. Nano Today 9 (2014), 401–404.
138. Kennedy, A.D., Wardenburg, J.B., Gardner, D.J., Long, D., Whitney, A.R., Braughton, K.R., Schneewind, O., DeLeo, F.R., Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model. J. Infect. Dis. 202 (2010), 1050–1058.
139. Kernodle, D.S., Expectations regarding vaccines and immune therapies directed against Staphylococcus aureus alpha-hemolysin. J. Infect. Dis. 203 (2011), 1692–1693.
140. Wei, X., Gao, J., Wang, F., Ying, M., Angsantikul, P., Kroll, A.V., Zhou, J., Gao, W., Lu, W., Fang, R.H., Zhang, L., In situ capture of bacterial toxins for antivirulence vaccination. Adv. Mater., 29, 2017, 1701644.
141. Gao, W., Fang, R.H., Thamphiwatana, S., Luk, B.T., Li, J.M., Angsantikul, P., Zhang, Q.Z., Hu, C.M.J., Zhang, L., Modulating antibacterial immunity via bacterial membrane-coated nanoparticles. Nano Lett. 15 (2015), 1403–1409.
142. Poetsch, A., Wdlters, D., Bacterial membrane proteomics. Proteomics 8 (2008), 4100–4122.
143. Lee, E.Y., Bang, J.Y., Park, G.W., Choi, D.S., Kang, J.S., Kim, H.J., Park, K.S., Lee, J.O., Kim, Y.K., Kwon, K.H., Kim, K.P., Gho, Y.S., Global proteomic profiling of native outer membrane vesicles derived from Escherichia coli. Proteomics 7 (2007), 3143–3153.
144. Luk, B.T., Hu, C.M.J., Fang, R.N.H., Dehaini, D., Carpenter, C., Gao, W., Zhang, L., Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles. Nanoscale 6 (2014), 2730–2737.
145. Rai, M., Yadav, A., Gade, A., Silver nanoparticles as a new generation of antimicrobials. Biotechnol. Adv. 27 (2009), 76–83.
146. Jones, N., Ray, B., Ranjit, K.T., Manna, A.C., Antibacterial activity of zno nanoparticle suspensions on a broad spectrum of microorganisms. FEMS Microbiol. Lett. 279 (2008), 71–76.
147. Henry, B.D., Neill, D.R., Becker, K.A., Gore, S., Bricio-Moreno, L., Ziobro, R., Edwards, M.J., Muhlemann, K., Steinmann, J., Kleuser, B., Japtok, L., Luginbuhl, M., Wolfmeier, H., Scherag, A., Gulbins, E., Kadioglu, A., Draeger, A., Babiychuk, E.B., Engineered liposomes sequester bacterial exotoxins and protect from severe invasive infections in mice. Nat. Biotechnol. 33 (2015), 81–88.
148. Anselmo, A.C., Mitragotri, S., Nanoparticles in the clinic. Bioeng. Transl. Med. 1 (2016), 10–29.